Vicore Pharma Holding AB (VCRE) Stock Price, Quote, News & History

VCRENASDAQ
$12.50
0.504.17%
At close: Aug 21, 5:00 PM EST
$11.86
-0.64-5.12%
After Hours: Aug 19, 9:07 AM EST
Loading...

Key Statistics

Open
$12.02
Close
$12.50
Volume / Avg.
4.73K / 33.79K
Day Range
$11.48 - $12.50
52 Wk Range
10.50 - 17.80
Market Cap
$333.89M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
-
Days to Cover
5.39

Recent Vicore Pharma Holding AB News

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-456.73M
Investing Cash Flow (TTM)
100.12M
Financing Cash Flow (TTM)
430.53M
Free Cash Flow (TTM)
-456.73M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
73.92M

Valuation Metrics

Enterprise Value
$231.16M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
816.54
PB Ratio (TTM)
3.25
Earnings Yield % (TTM)
-16.60%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.69

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$428.59M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$12.02
Close
$12.50
Volume / Avg.
4.73K / 33.79K
Day Range
$11.48 - $12.50
52 Wk Range
10.50 - 17.80
Market Cap
$333.89M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
-
Days to Cover
5.39

About

Sector
Health Care
Industry
Biotechnology
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an or...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vicore Pharma Holding (VCRE) stock?

A

You can purchase shares of Vicore Pharma Holding (NASDAQ:VCRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vicore Pharma Holding (VCRE) competitors?

Q

What is the forecast, or price target, for Vicore Pharma Holding (VCRE) stock?

A

There is no analysis for Vicore Pharma Holding to provide a consensus price target.

Q

What is the current price for Vicore Pharma Holding (VCRE)?

A

The stock price for Vicore Pharma Holding (NASDAQ: VCRE) is $11.86 last updated August 19, 2026 at 9:07 AM EDT.

Q

Does Vicore Pharma Holding (VCRE) pay a dividend?

A

There are no upcoming dividends for Vicore Pharma Holding.

Q

When is Vicore Pharma Holding (NASDAQ:VCRE) reporting earnings?

A

Vicore Pharma Holding does not have any upcoming earnings scheduled.

Q

Is Vicore Pharma Holding (VCRE) going to split?

A

There is no upcoming split for Vicore Pharma Holding.

Q

What sector and industry does Vicore Pharma Holding (VCRE) operate in?

A

Vicore Pharma Holding is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.